ApiFix Gains FDA Approval for MID-C Scoliosis Treatment

ApiFix received FDA approval under a Humanitarian Device Exemption to market the MID-C Minimally Invasive Deformity Correction system to treat adolescent idiopathic scoliosis (AIS).

FDA claims this to be the first posterior non-fusion device to treat adolescents with idiopathic scoliosis.

MID-C was developed as a less invasive...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us